Given that RPA2 expression in ascites tumor cells (5-year survival rate, 0.83 vs 0.68, P = 0.724; median PFS, 11.3 months vs. 19.8 months, P = 0.418) was weakly correlated with poor prognosis of HGSC patients in training cohort (Figure 1(f)), it was not included in subsequent analyses. Here, RPA2 is linked to neoplasm.